Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis

Digestive and Liver Disease

Volumn 43, Issue 12, 2011, Pages 1027-1028

  Marzano, Alfredo ^a   Marengo, Andrea ^a   Marietti, Milena ^a   Rizzetto, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; ENTECAVIR; LACTIC ACID; VIRUS DNA;

ADULT; AGE; AGED; ANTIVIRAL THERAPY; ARTERIAL PH; ASPERGILLUS FUMIGATUS; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; GENDER; GLOMERULUS FILTRATION RATE; HEPATITIS B VIRUS; HUMAN; HYPERLACTATEMIA; INTERNATIONAL NORMALIZED RATIO; LACTATE BLOOD LEVEL; LACTIC ACIDEMIA; LACTIC ACIDOSIS; LETTER; LIVER CIRRHOSIS; LIVER FUNCTION; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEPTIC SHOCK; TREATMENT DURATION;

ACIDOSIS, LACTIC; AGED; ANTIVIRAL AGENTS; END STAGE LIVER DISEASE; GUANINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 80055087027     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.06.013     Document Type: Letter

References (4)

1. Lange C., Bojunga J., Hofmann W.P., et al. Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function. Hepatology 2009, 50:2001-2006.
2. Shim J.H., Lee H.C., Kim K.M., et al. Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis. J Hepatol 2010, 52:176-182.
3. Liaw Y.F., Sheen I.S., Lee C.M., et al. Tenofovir Disoproxil Fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. Hepatology 2011, 53:62-72.
4. Fontana R.J. Entecavir in decompensated HBV cirrhosis: the future is looking brighter. J Hepatol 2010, 52:147-149.